WO2004003019A2
(en)
|
2002-06-28 |
2004-01-08 |
Domantis Limited |
Immunoglobin single variant antigen-binding domains and dual-specific constructs
|
EP1433793A4
(en)
*
|
2001-09-13 |
2006-01-25 |
Inst Antibodies Co Ltd |
Method of constructing camel antibody library
|
JP2005289809A
(en)
|
2001-10-24 |
2005-10-20 |
Vlaams Interuniversitair Inst Voor Biotechnologie Vzw (Vib Vzw) |
Mutant heavy-chain antibody
|
US20060034845A1
(en)
|
2002-11-08 |
2006-02-16 |
Karen Silence |
Single domain antibodies directed against tumor necrosis factor alpha and uses therefor
|
WO2004041865A2
(en)
|
2002-11-08 |
2004-05-21 |
Ablynx N.V. |
Stabilized single domain antibodies
|
US9320792B2
(en)
|
2002-11-08 |
2016-04-26 |
Ablynx N.V. |
Pulmonary administration of immunoglobulin single variable domains and constructs thereof
|
EP1613737A4
(en)
*
|
2003-03-28 |
2008-12-03 |
Receptors Llc |
Artificial receptors including reversibly immobilized building blocks and methods
|
US20060024746A1
(en)
*
|
2004-07-14 |
2006-02-02 |
Artann Laboratories, Inc. |
Methods and devices for optical monitoring and rapid analysis of drying droplets
|
US7563443B2
(en)
|
2004-09-17 |
2009-07-21 |
Domantis Limited |
Monovalent anti-CD40L antibody polypeptides and compositions thereof
|
WO2006055371A2
(en)
*
|
2004-11-16 |
2006-05-26 |
Alexion Pharmaceuticals, Inc. |
Functional screening of antibody libraries
|
FR2879605B1
(en)
*
|
2004-12-16 |
2008-10-17 |
Centre Nat Rech Scient Cnrse |
PRODUCTION OF ANTIBODY FORMATS AND IMMUNOLOGICAL APPLICATIONS OF THESE FORMATS
|
US7883858B2
(en)
*
|
2005-01-27 |
2011-02-08 |
Institute For Systems Biology |
Methods for identifying and monitoring drug side effects
|
EP1888640B1
(en)
|
2005-05-18 |
2012-03-14 |
Ablynx N.V. |
Improved nanobodies against tumor necrosis factor-alpha
|
PL3415535T3
(en)
|
2005-05-20 |
2021-06-14 |
Ablynx N.V. |
Improved nanobodies tm for the treatment of aggregation-mediated disorders
|
DE102005023617A1
(en)
|
2005-05-21 |
2006-11-23 |
Aspre Ag |
Method for mixing colors in a display
|
PL2698166T3
(en)
|
2006-10-10 |
2016-03-31 |
Regenesance B V |
Complement inhibition for improved nerve regeneration
|
WO2008074840A2
(en)
|
2006-12-19 |
2008-06-26 |
Ablynx N.V. |
Amino acid sequences directed against a metalloproteinase from the adam family and polypeptides comprising the same for the treatment of adam-related diseases and disorders
|
EP2557090A3
(en)
|
2006-12-19 |
2013-05-29 |
Ablynx N.V. |
Amino acid sequences directed against GPCRs and polypeptides comprising the same for the treatment of GPCR-related diseases and disorders
|
US9023352B2
(en)
*
|
2007-02-20 |
2015-05-05 |
Tufts University |
Methods, compositions and kits for treating a subject using a recombinant heteromultimeric neutralizing binding protein
|
DK2308514T3
(en)
|
2007-03-23 |
2013-09-02 |
To Bbb Holding B V |
Conjugates for targeted drug transport through the blood-brain barrier
|
CA2691940C
(en)
|
2007-07-03 |
2018-03-06 |
Joost Alexander Kolkman |
Methods for providing improved immunoglobulin sequences
|
JP2010533004A
(en)
|
2007-07-13 |
2010-10-21 |
バク アイピー ベスローテン フェンノートシャップ |
Single domain antigen binding protein that binds to mammalian IgG
|
CA2698419C
(en)
*
|
2007-09-07 |
2019-11-12 |
Edward Dolk |
Binding molecules with multiple binding sites, compositions comprising the same and uses thereof
|
WO2009108170A2
(en)
*
|
2007-11-16 |
2009-09-03 |
Invitrogen Corporation |
Compositions and methods for determining immune status
|
WO2009068630A1
(en)
|
2007-11-27 |
2009-06-04 |
Ablynx N.V. |
Immunoglobulin constructs
|
US20110091462A1
(en)
|
2008-03-05 |
2011-04-21 |
Ablynx N.V. |
Novel antigen binding dimer-complexes, methods of making and uses thereof
|
WO2009124931A2
(en)
|
2008-04-07 |
2009-10-15 |
Ablynx Nv |
Amino acid sequences directed against the notch pathways and uses thereof
|
AU2009237662A1
(en)
|
2008-04-17 |
2009-10-22 |
Ablynx N.V. |
Peptides capable of binding to serum proteins and compounds, constructs and polypeptides comprising the same
|
CN102271707B
(en)
|
2008-10-29 |
2015-04-08 |
阿布林克斯公司 |
Formulations of single domain antigen binding molecules
|
WO2010056550A1
(en)
|
2008-10-29 |
2010-05-20 |
Wyeth Llc |
Methods for purification of single domain antigen binding molecules
|
WO2010100135A1
(en)
|
2009-03-05 |
2010-09-10 |
Ablynx N.V. |
Novel antigen binding dimer-complexes, methods of making/avoiding and uses thereof
|
PT2424889E
(en)
|
2009-04-30 |
2015-11-12 |
Ablynx Nv |
Method for the production of domain antibodies
|
WO2011003622A1
(en)
|
2009-07-10 |
2011-01-13 |
Ablynx N.V. |
Method for the production of variable domains
|
EP2473527B1
(en)
|
2009-09-03 |
2016-11-30 |
Ablynx N.V. |
Stable formulations of polypeptides and uses thereof
|
WO2011083140A1
(en)
|
2010-01-08 |
2011-07-14 |
Ablynx Nv |
Immunoglobulin single variable domain directed against human cxcr4
|
JP2013518853A
(en)
|
2010-02-05 |
2013-05-23 |
アブリンクス エン.ヴェー. |
Peptides capable of binding to serum albumin and compounds, constructs and polypeptides containing the same
|
CN105380904A
(en)
|
2010-02-11 |
2016-03-09 |
埃博灵克斯股份有限公司 |
Methods and compositions for the preparation of aerosols
|
US9101674B2
(en)
|
2010-03-29 |
2015-08-11 |
Vib Vzw |
Targeting and in vivo imaging of tumor-associated macrophages
|
US9556273B2
(en)
|
2010-03-29 |
2017-01-31 |
Vib Vzw |
Anti-macrophage mannose receptor single variable domains for targeting and in vivo imaging of tumor-associated macrophages
|
WO2011161263A1
(en)
|
2010-06-25 |
2011-12-29 |
Ablynx Nv |
Pharmaceutical compositions for cutaneous administration
|
NO2632946T3
(en)
|
2010-10-29 |
2018-05-05 |
|
|
WO2012105833A1
(en)
*
|
2011-02-01 |
2012-08-09 |
Bac Ip B.V. |
Antigen-binding protein directed against epitope in the ch1 domain of human igg antibodies
|
PT2691415T
(en)
|
2011-03-28 |
2018-10-19 |
Ablynx Nv |
Method for producing solid formulations comprising immunoglobulin single variable domains
|
EP2707382B1
(en)
|
2011-05-09 |
2019-07-17 |
Ablynx NV |
Method for the production of immunoglobulin single variable domains
|
CN108329391A
(en)
|
2011-05-27 |
2018-07-27 |
埃博灵克斯股份有限公司 |
Inhibit bone absorption using RANKL binding peptides
|
JP2014525736A
(en)
|
2011-06-23 |
2014-10-02 |
アブリンクス エン.ヴェー. |
Immunoglobulin single variable domain for IgE
|
WO2013041901A1
(en)
*
|
2011-09-20 |
2013-03-28 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods for preparing single domain antibody microarrays
|
EP2747782B1
(en)
|
2011-09-23 |
2018-01-17 |
Ablynx NV |
Prolonged inhibition of interleukin-6 mediated signaling
|
US10112988B2
(en)
|
2012-01-09 |
2018-10-30 |
Icb International, Inc. |
Methods of assessing amyloid-beta peptides in the central nervous system by blood-brain barrier permeable peptide compositions comprising a vab domain of a camelid single domain heavy chain antibody against an anti-amyloid-beta peptide
|
US10112987B2
(en)
|
2012-01-09 |
2018-10-30 |
Icb International, Inc. |
Blood-brain barrier permeable peptide compositions comprising a vab domain of a camelid single domain heavy chain antibody against an amyloid-beta peptide
|
JP6411333B2
(en)
|
2012-05-24 |
2018-10-24 |
ブイアイビー ブイゼットダブリュVib Vzw |
Anti-macrophage mannose receptor single variable domain for tumor-associated macrophage targeting and INVIVO imaging
|
US20140046722A1
(en)
*
|
2012-08-10 |
2014-02-13 |
Sample6 Technologies, Inc. |
System for on-site environment monitoring
|
WO2014087010A1
(en)
|
2012-12-07 |
2014-06-12 |
Ablynx N.V. |
IMPROVED POLYPEPTIDES DIRECTED AGAINST IgE
|
DK2951201T3
(en)
|
2013-01-30 |
2018-01-08 |
Vib Vzw |
Novel chimeric polypeptides for screening and drug detection purposes
|
AU2014214054B2
(en)
|
2013-02-05 |
2018-10-04 |
The Board Of Trustees Of The Leland Stanford Junior University |
Muscarinic acetylcholine receptor binding agents and uses thereof
|
AU2014229952B2
(en)
|
2013-03-15 |
2018-10-04 |
Vib Vzw |
Anti-macrophage mannose receptor single variable domains for use in cardiovascular diseases
|
PT2992100T
(en)
|
2013-04-29 |
2019-12-16 |
Agrosavfe Nv |
Agrochemical compositions comprising antibodies binding to sphingolipids
|
NL1040254C2
(en)
|
2013-05-17 |
2014-11-24 |
Ablynx Nv |
Stable formulations of immunoglobulin single variable domains and uses thereof.
|
FR3007411B1
(en)
*
|
2013-06-21 |
2015-07-03 |
Agronomique Inst Nat Rech |
MONOCATENARY ANTIBODY TO CAMPHIDE HEAVY CHAIN AGAINST CHROMATIN AND USES THEREOF
|
EP2883883A1
(en)
|
2013-12-16 |
2015-06-17 |
Cardio3 Biosciences S.A. |
Therapeutic targets and agents useful in treating ischemia reperfusion injury
|
EP3099707B1
(en)
|
2014-01-30 |
2021-12-29 |
Vib Vzw |
Opioid receptor binding agents and uses thereof
|
NL2013661B1
(en)
|
2014-10-21 |
2016-10-05 |
Ablynx Nv |
KV1.3 Binding immunoglobulins.
|
US20180036442A1
(en)
|
2014-07-29 |
2018-02-08 |
Vrije Universiteit Brussel |
Radio-labelled antibody fragments for use in the prognosis, diagnosis of cancer as well as for the prediction of cancer therapy response
|
WO2016016021A1
(en)
|
2014-07-29 |
2016-02-04 |
Vrije Universiteit Brussel |
Radio-labelled antibody fragments for use in the prevention and/or treatment of cancer
|
JP7089877B2
(en)
|
2014-11-05 |
2022-06-23 |
バイオタリス・エン・フェー |
Transgenic plants containing polynucleotides encoding variable domains of heavy chain antibodies
|
PT3233910T
(en)
|
2014-12-19 |
2020-03-17 |
Ablynx Nv |
Cysteine linked nanobody dimers
|
US11298433B2
(en)
|
2015-07-17 |
2022-04-12 |
Vrije Universiteit Brussel |
Radiolabelled antibody fragments for use in treating cancer
|
RU2018122255A
(en)
|
2015-11-27 |
2019-12-19 |
Аблинкс Нв |
CD40L INHIBITING POLYPEPTIDES
|
WO2017182605A1
(en)
|
2016-04-22 |
2017-10-26 |
Université Libre de Bruxelles |
A new biomarker expressed in pancreatic beta cells useful in imaging or targeting beta cells
|
US11243214B2
(en)
|
2016-04-22 |
2022-02-08 |
Université Libre de Bruxelles |
Biomarker expressed in pancreatic beta cells useful in imaging or targeting beta cells
|
CA3022697A1
(en)
|
2016-05-02 |
2017-11-09 |
Ablynx Nv |
Treatment of rsv infection
|
WO2018007442A1
(en)
|
2016-07-06 |
2018-01-11 |
Ablynx N.V. |
Treatment of il-6r related diseases
|
WO2018029182A1
(en)
|
2016-08-08 |
2018-02-15 |
Ablynx N.V. |
Il-6r single variable domain antibodies for treatment of il-6r related diseases
|
EP3512880A1
(en)
|
2016-09-15 |
2019-07-24 |
Ablynx NV |
Immunoglobulin single variable domains directed against macrophage migration inhibitory factor
|
CA3043515A1
(en)
|
2016-11-16 |
2018-05-24 |
Ablynx Nv |
T cell recruiting polypeptides capable of binding cd123 and tcr alpha/beta
|
WO2018099968A1
(en)
|
2016-11-29 |
2018-06-07 |
Ablynx N.V. |
Treatment of infection by respiratory syncytial virus (rsv)
|
WO2018158335A1
(en)
|
2017-02-28 |
2018-09-07 |
Vib Vzw |
Means and methods for oral protein delivery
|
US20200033347A1
(en)
|
2017-04-18 |
2020-01-30 |
Universite Libre De Bruxelles |
Biomarkers And Targets For Proliferative Diseases
|
WO2018206734A1
(en)
|
2017-05-11 |
2018-11-15 |
Vib Vzw |
Glycosylation of variable immunoglobulin domains
|
EP3630818A1
(en)
|
2017-06-02 |
2020-04-08 |
Ablynx NV |
Aggrecan binding immunoglobulins
|
MX2019014400A
(en)
|
2017-06-02 |
2020-02-10 |
Merck Patent Gmbh |
Adamts binding immunoglobulins.
|
CA3064469A1
(en)
|
2017-06-02 |
2018-12-06 |
Merck Patent Gmbh |
Mmp13 binding immunoglobulins
|
MX2019014397A
(en)
|
2017-06-02 |
2020-02-10 |
Merck Patent Gmbh |
Polypeptides binding adamts5, mmp13 and aggrecan.
|
KR102625929B1
(en)
|
2017-07-19 |
2024-01-16 |
브이아이비 브이지더블유 |
Serum albumin binder
|
EP3470436A1
(en)
*
|
2017-10-11 |
2019-04-17 |
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. |
Anti-igg nanobodies
|
US11873347B2
(en)
|
2017-10-31 |
2024-01-16 |
Vib Vzw |
Antigen-binding chimeric proteins and methods and uses thereof
|
WO2019155041A1
(en)
|
2018-02-12 |
2019-08-15 |
Vib Vzw |
Gβγ COMPLEX ANTIBODIES AND USES THEREOF
|
CA3092421A1
(en)
|
2018-03-01 |
2019-09-06 |
Vrije Universiteit Brussel |
Human pd-l1-binding immunoglobulins
|
PL3768701T3
(en)
|
2018-03-23 |
2024-02-19 |
Université Libre de Bruxelles |
Wnt signaling agonist molecules
|
US20210023187A1
(en)
|
2018-03-27 |
2021-01-28 |
Umc Utrecht Holding B.V. |
Targeted Thrombolysis for Treatment of Microvascular Thrombosis
|
CN108659131B
(en)
*
|
2018-05-28 |
2021-09-14 |
长春力太生物技术有限公司 |
anti-CEACAM-5 single-domain antibody and application thereof
|
SG11202111830UA
(en)
|
2019-04-29 |
2021-11-29 |
Confo Therapeutics N V |
Chimeric proteins and methods to screen for compounds and ligands binding to gpcrs
|
EP3962599A1
(en)
|
2019-04-30 |
2022-03-09 |
Vib Vzw |
Cystic fibrosis transmembrane conductance regulator stabilizing agents
|
EP3976067A1
(en)
|
2019-05-28 |
2022-04-06 |
Vib Vzw |
Cd8+ t-cells lacking plexins and their application in cancer treatment
|
WO2020239945A1
(en)
|
2019-05-28 |
2020-12-03 |
Vib Vzw |
Cancer treatment by targeting plexins in the immune compartment
|
US11414785B2
(en)
|
2019-08-13 |
2022-08-16 |
Waters Technologies Corporation |
Affinity resins and sample preparation devices based on cartilaginous fish IgNAR derived binding domains
|
WO2021078786A1
(en)
|
2019-10-21 |
2021-04-29 |
Vib Vzw |
Nanodisc-specific antigen-binding chimeric proteins
|
AU2020384953A1
(en)
|
2019-11-11 |
2022-06-23 |
Ibi-Ag Innovative Bio Insecticides Ltd. |
Insect control nanobodies and uses thereof
|
WO2021105438A1
(en)
|
2019-11-27 |
2021-06-03 |
Vib Vzw |
Positive allosteric modulators of the calcium-sensing receptor
|
GB201918279D0
(en)
|
2019-12-12 |
2020-01-29 |
Vib Vzw |
Glycosylated single chain immunoglobulin domains
|
JP2023506961A
(en)
|
2019-12-20 |
2023-02-20 |
フエー・イー・ベー・フエー・ゼツト・ウエー |
Nanobody exchange chromatography
|
WO2021140205A1
(en)
|
2020-01-10 |
2021-07-15 |
Confo Therapeutics N.V. |
Methods for generating antibodies and antibody fragments and libraries comprising same
|
WO2021156490A2
(en)
|
2020-02-06 |
2021-08-12 |
Vib Vzw |
Corona virus binders
|
IL295892A
(en)
|
2020-02-25 |
2022-10-01 |
Vib Vzw |
Leucine-rich repeat kinase 2 allosteric modulators
|
CA3178461A1
(en)
|
2020-03-31 |
2021-10-07 |
Biotalys NV |
Anti-fungal polypeptides
|
EP4144758A4
(en)
|
2020-04-22 |
2024-05-15 |
Mabwell Shanghai Bioscience Co Ltd |
Single variable domain antibody targeting human programmed death ligand 1 (pd-l1) and derivative thereof
|
WO2021229104A1
(en)
|
2020-05-15 |
2021-11-18 |
Université de Liège |
Anti-cd38 single-domain antibodies in disease monitoring and treatment
|
WO2022003156A1
(en)
|
2020-07-02 |
2022-01-06 |
Oncurious Nv |
Ccr8 non-blocking binders
|
IL300173A
(en)
|
2020-07-31 |
2023-03-01 |
Biotalys NV |
Expression host
|
KR20220026401A
(en)
|
2020-08-25 |
2022-03-04 |
주식회사 에프티넷 |
Aluminum alloy for flux-free brazing and brazing method using the same
|
EP4216943A1
(en)
|
2020-09-24 |
2023-08-02 |
Vib Vzw |
Combination of p2y6 inhibitors and immune checkpoint inhibitors
|
WO2022063957A1
(en)
|
2020-09-24 |
2022-03-31 |
Vib Vzw |
Biomarker for anti-tumor therapy
|
EP4217390A1
(en)
|
2020-09-25 |
2023-08-02 |
Ablynx N.V. |
Polypeptides comprising immunoglobulin single variable domains targeting il-13 and ox40l
|
WO2022117572A2
(en)
|
2020-12-02 |
2022-06-09 |
Oncurious Nv |
An ltbr agonist in combination therapy against cancer
|
WO2022117569A1
(en)
|
2020-12-02 |
2022-06-09 |
Oncurious Nv |
A ccr8 antagonist antibody in combination with a lymphotoxin beta receptor agonist antibody in therapy against cancer
|
EP4263602A1
(en)
|
2020-12-18 |
2023-10-25 |
Ablynx N.V. |
Polypeptides comprising immunoglobulin single variable domains targeting il-6 and tnf-alpha
|
GB202020502D0
(en)
|
2020-12-23 |
2021-02-03 |
Vib Vzw |
Antibody composistion for treatment of corona virus infection
|
WO2022136649A1
(en)
|
2020-12-24 |
2022-06-30 |
Oncurious Nv |
Non-blocking human ccr8 binders
|
WO2022136650A1
(en)
|
2020-12-24 |
2022-06-30 |
Oncurious Nv |
Murine cross-reactive human ccr8 binders
|
US20240076391A1
(en)
|
2020-12-24 |
2024-03-07 |
Oncurious Nv |
Human ccr8 binders
|
EP4288095A1
(en)
|
2021-02-05 |
2023-12-13 |
Vib Vzw |
Sarbecovirus binders
|
CN117794566A
(en)
|
2021-02-05 |
2024-03-29 |
Vib研究所 |
Sha Bei viral binding agents
|
WO2022175392A1
(en)
|
2021-02-17 |
2022-08-25 |
Vib Vzw |
Inhibition of slc4a4 in the treatment of cancer
|
CA3211270A1
(en)
|
2021-02-19 |
2022-08-25 |
Vib Vzw |
Cation-independent mannose-6-phosphate receptor binders
|
WO2022199804A1
(en)
|
2021-03-24 |
2022-09-29 |
Vib Vzw |
Nek6 inhibition to treat als and ftd
|
WO2022242892A1
(en)
|
2021-05-17 |
2022-11-24 |
Université de Liège |
Anti-cd38 single-domain antibodies in disease monitoring and treatment
|
CA3225194A1
(en)
|
2021-06-23 |
2022-12-29 |
Vib Vzw |
Means and methods for selection of specific binders
|
CN117580865A
(en)
|
2021-06-29 |
2024-02-20 |
山东先声生物制药有限公司 |
CD16 antibodies and uses thereof
|
KR20240027117A
(en)
*
|
2021-07-01 |
2024-02-29 |
닝보 티-맥시멈 바이오파마슈티컬스 컴퍼니 리미티드 |
Antigen-binding polypeptide targeting B7H3 and its applications
|
WO2023016828A2
(en)
|
2021-07-30 |
2023-02-16 |
Vib Vzw |
Cation-independent mannose-6-phosphate receptor binders for targeted protein degradation
|
AU2022320667A1
(en)
|
2021-07-30 |
2024-03-14 |
Shandong Simcere Biopharmaceutical Co., Ltd. |
Anti-pvrig/anti-tigit bispecific antibody and application
|
WO2023057601A1
(en)
|
2021-10-06 |
2023-04-13 |
Biotalys NV |
Anti-fungal polypeptides
|
WO2023111266A1
(en)
|
2021-12-17 |
2023-06-22 |
Ablynx Nv |
POLYPEPTIDES COMPRISING IMMUNOGLOBULIN SINGLE VARIABLE DOMAINS TARGETING TCRαβ, CD33 AND CD123
|
WO2023135198A1
(en)
|
2022-01-12 |
2023-07-20 |
Vib Vzw |
Human ntcp binders for therapeutic use and liver-specific targeted delivery
|
WO2023148291A1
(en)
|
2022-02-02 |
2023-08-10 |
Biotalys NV |
Methods for genome editing
|
WO2023148397A1
(en)
|
2022-02-07 |
2023-08-10 |
Vib Vzw |
Engineered stabilizing aglycosylated fc-regions
|
WO2023198848A1
(en)
|
2022-04-13 |
2023-10-19 |
Vib Vzw |
An ltbr agonist in combination therapy against cancer
|
WO2023213751A1
(en)
|
2022-05-02 |
2023-11-09 |
Umc Utrecht Holding B.V |
Single domain antibodies for the detection of plasmin-cleaved vwf
|
WO2023222825A1
(en)
|
2022-05-18 |
2023-11-23 |
Vib Vzw |
Sarbecovirus spike s2 subunit binders
|
WO2024008755A1
(en)
|
2022-07-04 |
2024-01-11 |
Vib Vzw |
Blood-cerebrospinal fluid barrier crossing antibodies
|
WO2024068744A1
(en)
|
2022-09-27 |
2024-04-04 |
Vib Vzw |
Antivirals against human parainfluenza virus
|